Growth Metrics

Balchem (BCPC) Liabilities and Shareholders Equity (2016 - 2026)

Balchem (BCPC) has disclosed Liabilities and Shareholders Equity for 17 consecutive years, with $1.7 billion as the latest value for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity rose 4.71% year-over-year to $1.7 billion; the TTM value through Mar 2026 reached $6.7 billion, up 5.57%, while the annual FY2025 figure was $1.7 billion, 7.04% up from the prior year.
  • Liabilities and Shareholders Equity hit $1.7 billion in Q1 2026 for Balchem, roughly flat from $1.7 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $1.7 billion in Q1 2026 and bottomed at $1.2 billion in Q1 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2025.
  • Year-over-year, Liabilities and Shareholders Equity skyrocketed 38.47% in 2022 and then fell 2.73% in 2024.
  • Balchem's Liabilities and Shareholders Equity stood at $1.6 billion in 2022, then fell by 1.68% to $1.6 billion in 2023, then decreased by 1.37% to $1.6 billion in 2024, then increased by 7.04% to $1.7 billion in 2025, then rose by 0.44% to $1.7 billion in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $1.7 billion, $1.7 billion, and $1.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.